Protocols
1 protocol(s) meet the specified criteria
Drug: MLN0128
Protocol No.TitleStatus
BTCRC-GI13-002An Open Label Randomized Phase I/II Trial of TAK-228 Compared to Sorafenib in Patients with Advanced or Metastatic Hepatocellular CarcinomaOpen